title: [Membranous nephropathy].
authors.forename: Yukio
authors.initials: Y
authors.lastname: Yuzawa
authors.forename: Midori
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Nabeshima
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D001323:Autoantibodies; D003167:Complement Activation; D015938:Complement Membrane Attack Complex; D015433:Glomerulonephritis, Membranous / Q000145:classification / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015260:Neprilysin / Q000276:immunology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D054507:Receptors, Phospholipase A2 / Q000276:immunology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001323:Autoantibodies; D015938:Complement Membrane Attack Complex; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D054507:Receptors, Phospholipase A2; D011239:Prednisolone; D015260:Neprilysin